LABORATORY MICROFUSION CAPABILITY PHASE-II STUDY

被引:0
|
作者
MCALLISTER, GL
机构
来源
FUSION TECHNOLOGY | 1994年 / 26卷 / 03期
关键词
D O I
10.13182/FST94-A40245
中图分类号
TL [原子能技术]; O571 [原子核物理学];
学科分类号
0827 ; 082701 ;
摘要
As part of the Laboratory Microfusion Capability (LMC) Phase II Study, Bechtel Corporation carried out an independent cost study for the Department of Energy, comparing the three more detailed proposals for the Laboratory Microfusion Facility (LMF): the neodymium-glass (Nd:glass) solid state laser; the light-ion accelerator; and the krypton fluoride (KrF) excimer gas laser. The cost study tasks centered on developing the Work Breakdown Structure (WBS) and the methodology for costing technologies in different stages of development in order to produce, for the three proposals, cost estimates with a common basis. In addition to the equipment and facility costs, the cost estimates include system and design engineering, project management and administration, construction management, and contingency.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [1] A PHASE-II STUDY OF MITOXANTRONE
    CARTEI, G
    MIAN, S
    CENDRON, R
    LAMON, S
    CLOCCHIATTI, L
    FASOLA, G
    GALLETTI, D
    SIBAU, A
    TUMORI, 1988, 74 (05) : 579 - 583
  • [2] PHASE-II STUDY OF AZOTOMYCIN IN SARCOMAS
    CHANG, P
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1977, 61 (09): : 1719 - 1720
  • [3] BROAD PHASE-II STUDY OF VINDESINE
    VALDIVIESO, M
    BEDIKIAN, AY
    BODEY, GP
    FREIREICH, EJ
    CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 877 - 879
  • [4] A PHASE-II STUDY OF DIHYDROXYANTHRACENEDIONE (DHAD)
    ANDERSON, KC
    COHEN, G
    GARNICK, MB
    MESHAD, M
    CANELLOS, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 110 - 110
  • [5] MULTICENTER PHASE-II STUDY OF SPIROPLATIN
    TANIS, BC
    VERMORKEN, JB
    HUININK, WWT
    VANOOSTEROM, AT
    SPLINTER, TAW
    VENDRIK, KJ
    SLEIJFER, DTH
    VANDERBURG, MEL
    VANDERPUTTEN, E
    PINEDO, HM
    ONCOLOGY, 1992, 49 (02) : 99 - 103
  • [6] A PHASE-II STUDY OF BISANTRENE IN ANLL
    MARTY, M
    CLARK, MJ
    COLLADO, S
    CALVO, F
    GISSELBRECHT, C
    SCHAISON, G
    LAPORTE, JP
    NGUYENDINH, C
    BOIRON, M
    THERAPIE, 1986, 41 (06): : 523 - 523
  • [7] PHASE-II STUDY OF TAUROMUSTINE IN MALIGNANT GLIOMA
    GREGOR, A
    RAMPLING, R
    AAPRO, M
    MALMSTROM, P
    WHITTLE, IR
    RYE, R
    STEWART, M
    SELLAR, R
    DEMIERRE, B
    IRONSIDE, JW
    WAHLBY, S
    SMYTH, JF
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) : 1959 - 1962
  • [8] PHASE-II STUDY OF AZIRIDINYLBENZOQUINONE IN REFRACTORY LYMPHOMA
    CASE, DC
    HAYES, DM
    CANCER TREATMENT REPORTS, 1983, 67 (11): : 993 - 996
  • [9] PHASE-II STUDY OF MAYTANSINE IN ADVANCED SARCOMAS
    EDMONSON, JH
    HAHN, RG
    CREAGAN, ET
    OCONNELL, MJ
    CANCER TREATMENT REPORTS, 1983, 67 (04): : 401 - 402
  • [10] A PHASE-II STUDY OF CARBOPLATIN IN ADENOCARCINOMA OF THE ESOPHAGUS
    STEEL, A
    CULLEN, MH
    ROBERTSON, PW
    MATTHEWS, HR
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 500 - 501